异位症患者Fontan手术结局:848例荟萃分析
该系统综述与荟萃分析纳入21项研究共848例异位症Fontan术后患者,早期死亡加权事件率为14%(95%CI 10%-19%),1、5、10年生存率分别为86%、80%、74%。研究期中位年份≥1995年的研究10年生存率优于更早研究(P=.02)。与整体Fontan人群相比,异位症患者早期死亡率更高,但长期生存相当。
要点
- 异位症Fontan术后早期死亡加权事件率14%(95%CI 10%-19%)。
- 1、5、10年生存率分别为86%、80%、74%。
- 研究期中位年份≥1995年的研究10年生存率更优(P=.02)。
核心结论
- 异位症患者Fontan术后早期死亡率高于整体Fontan人群,长期生存与整体Fontan队列相当。
- 异位症患者成功过渡至Fontan后,后续生存可接受且可预测。
研究设计与样本
- 系统综述与荟萃分析,纳入21项研究共848例异位症Fontan术后患者。
- 按研究时期、队列规模和右/左心房异构比例进行分层分析。
主要发现
- 早期死亡率介于1%至30%,加权事件率为14%(95%CI 10%-19%)。
- 1年生存率86%(95%CI 79%-91%),5年生存率80%(95%CI 71%-87%),10年生存率74%(95%CI 59%-85%)。
- 研究期中位年份≥1995年的研究10年生存率优于更早研究(P=.02)。
- 按队列规模和右/左心房异构比例分层未见亚组差异。
临床怎么用
- 咨询异位症Fontan候选患者时应告知早期死亡风险较高但长期生存可接受。
局限性
- 长期随访数据缺乏。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Heterotaxy is considered a risk factor for adverse events at all stages in the pre-Fontan pathway, and Fontan outcomes are expected to be worse in patients with heterotaxy. The aim of this study was to review existing literature reporting outcomes of the Fontan operation systematically in patients with heterotaxy. METHODS: A systematic review and meta-analysis was performed to identify and synthesize early mortality and medium- and long-term survival in heterotaxy patients after the Fontan procedure. Subsequent outcome analyses were stratified by study period era, cohort size, and proportion of right versus left atrial isomerism to explore predictors of outcome. RESULTS: A total of 21 studies were included for analysis, which were composed of 848 post-Fontan heterotaxy patients. Early mortality varied between 1% and 30% with a weighted event rate of 14% (95% confidence interval [CI], 10%-19%). Survival at 1, 5, and 10 years was 86% (95% CI, 79%-91%), 80% (95% CI, 71%-87%), and 74% (95% CI, 59%-85%), respectively. Stratification by study period highlighted that studies with a median study period year of 1995 or later had similar early mortality and 1- and 5-year survival, but superior 10-year survival (P = .02) compared with earlier studies. Stratification by cohort size and right versus left atrial isomerism did not reveal subgroup differences. CONCLUSIONS: Compared with existing literature, in patients with heterotaxy, early mortality after Fontan is higher than for the overall Fontan population. Long-term survival is comparable to the overall Fontan cohort. When heterotaxy patients are successfully transitioned to Fontan, subsequent survival is acceptable and predictable. Long-term follow-up is lacking.
引用
- Marathe SP, Cao JY, Celermajer D, et al. Outcomes of the Fontan Operation for Patients With Heterotaxy: A Meta-Analysis of 848 Patients. Ann Thorac Surg. 2020. PMID: 31926157. doi:10.1016/j.athoracsur.2019.11.027
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。